← FDA DRUG APPROVALS

FDA ANDA · ANDA075560

CIMETIDINE HYDROCHLORIDE

Sponsor: PHARM ASSOC

APPLICATION
ANDA075560
TYPE
ANDA
ORIGINAL APPROVAL
2000-03-15
LATEST ACTION
2001-01-26
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

CIMETIDINE HYDROCHLORIDEDiscontinued
CIMETIDINE HYDROCHLORIDE EQ 300MG BASE/5ML · SOLUTION · ORAL

Approval history

2001-01-26Manufacturing (CMC) · Supplement 3AP
2000-10-26Manufacturing (CMC) · Supplement 2AP
2000-03-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →